References

  1. Atkins C, Bonagura J, Ettinger S, et al. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009;23(6):1142–1150.
  2. Sisson D. Valvular heart disease in dogs. Proceedings from the WSAVA 2002 Congress; October 3–6, 2002; Granada, Spain.
    http://www.vin.com/proceedings/Proceedings.plx?CID=WSAVA2002&PID=2532. Accessed September 4, 2012.
  3. Guglielmini C. Cardiovascular disease in the aging dog: diagnostic and therapeutic problems. Vet Res Commun. 2003;27 Suppl 1:555–560.
  4. Buchanan JW. Prevalence of cardiovascular disorders. In: Fox PR, Sisson D, Moise NS, eds. Textbook of Canine and Feline Cardiology. Philadelphia, PA: WB Saunders; 1998:457–470.
  5. Oyama M. Congenital heart disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Saunders Elsevier; 2010:1250–1298.
  6. Olsen LH, Häggström J, Petersen HD. Acquired valvular heart disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Saunders Elsevier; 2010:1299–1319.
  7. Rush JE. Chronic valvular heart disease in dogs. Proceedings from the 26th Annual Waltham Diets/OSU Symposium for the Treatment of Small Animal Diseases Cardiology; October 19–20, 2002.
    http://www.vin.com/proceedings/Proceedings.plx?CID=WALTHAMOSU2002&PID=2988. Accessed September 4, 2012.
  8. O’Grady MR, Minors SL, O’Sullivan ML, Horne R. Effect of pimobendan on case fatality rate in Doberman pinschers with congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med. 2008;22(4):897–904.
  9. Buchanan JW, Bücheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc. 1995;206(2):194–199.
  10. Lamb CR, Wikeley H, Boswood A, Pfeiffer DU. Use of breed-specific ranges for the vertebral heart scale as an aid to the radiographic diagnosis of cardiac disease in dogs. Vet Rec. 2001;148(23):707–711.
  11. Bavegems V, Van Caelenberg A, Duchateau L, Sys SU, Van Bree H, De Rick A. Vertebral heart size ranges specific for whippets. Vet Radiol Ultrasound. 2005;46(5):400–403.
  12. Hansson K, Häggström J, Kvart C, Lord P. Interobserver variability of vertebral heart size measurements in dogs with normal and enlarged hearts. Vet Radiol Ultrasound. 2005;46(2):122–130.
  13. Pagel PS, Hettrick DA, Warltier DC. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthestized dogs. Br J Pharmacol. 1996;119(3):609–615.
  14. Gordon SG, Miller MW, Saunders AB. Pimobendan in heart failure—a silver bullet? J Am Anim Hosp Assoc. 2006;42(2):90–93.
  15. Fitton A, Brogden RN. Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure. Drugs Aging. 1994;4(5):417–441.
  16. Van Meel JCA, Diederen W. Hemodynamic profile of the cardiotonic agent pimobendan. J Cardiovasc Pharmacol. 1989;14(Suppl 29):S1–S6.
  17. Lombard CW, Jöns O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249–261.
  18. Häggström J, Boswood A, O’Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124–1135.
  19. Luis Fuentes V, Corcoran B, French A, Schober KE, Kleemann R, Justus C. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Intern Med. 2002;16(3):255–261.
Back to top